Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Rolenium vs Seretide in Asthma
NCT01484210Phase 3Completed
- Sponsor
- ELPEN
- Start
- Mar 2008
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate and salmeterol in asthma (2 arms), sponsored by ELPEN. Primary endpoint: 12-hour average Forced Expiratory Volume in 1 second. Started Mar 2008; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01484210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484210.